Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has undoubtedly
revolutionized the whole globe and given a new point of view on respiratory tract infections …

Importance Relatively little is known about the persistence of symptoms in patients with
COVID-19 for more than 1 year after their acute illness. Objective To assess the health …

Background Non-alcoholic fatty liver disease (NAFLD) patients represent a vulnerable
population that may be susceptible to more severe COVID-19. Moreover, not only the …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), has become a global epidemic and poses a major …

The COVID-19 pandemic has had considerable impact on alcohol use, with an increase in
alcohol related emergencies, changes in alcohol use patterns, increased risk of contracting …

The COVID-19 pandemic is the largest public health challenge in living memory. Patients
with underlying liver disease have been disproportionately affected, experiencing high …

Introduction Current evidence indicates that smoking worsens COVID-19 outcomes.
However, when studies restricted their analyses to current smokers, the risks for COVID-19 …

Background and Aims Data regarding outcome of COVID‐19 in patients with autoimmune
hepatitis (AIH) are lacking. Approach and Results We performed a retrospective study on …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Methods We collected data via three databases from inception to February 16, 2022, and
reported pooled seroconversion rate, T cell response and safety data after two vaccine …